Regencell Bioscience Holdings Ltd

RGC NYSE Santé & Biotech Monde KYG7487R1002
12.01 $
18.91 %

Regencell Bioscience Holdings Ltd développe des produits dérivés des cellules souches pour des applications en thérapie régénérative et médecine esthétique.

Performance & Momentum

6 Months 25.19 %
1 Year 61.01 %
3 Years 2 296 %
5 Years 4 246 %

Similar stocks to Regencell Bioscience Holdings Ltd

Anantys Community

Be the first to share your analysis on Regencell Bioscience Holdings Ltd.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases